Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-06

Clinical Trial Update: Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya [NA]

View source ↗

Summary

A clinical trial evaluating spatial repellent products for malaria prevention in Kenya has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Notre Dame | Conditions: Malaria | NA | Status: WITHDRAWN